SMS Pharmaceuticals Limited (SMSPHARMA) — Announcement | 22 July 2026
SMS Pharmaceuticals Limited announced on July 22, 2026 that it is sending reminder letters to shareholders who have not claimed dividends for seven or more consecutive years, requiring them to claim unpaid dividends by October 25, 2026 or risk compulsory transfer of shares to the Investor Education and Protection Fund (IEPF) as mandated by SEBI LODR Regulation 30 and Section 124(6) of the Companies Act, 2013. The filing details the procedural requirements for claiming dividends and the consequences of non-claim, including KYC compliance and documentation needed for electronic or physical shareholding. This regulatory action ensures compliance with investor protection norms but signals potential share transfers that could affect shareholding structures.
About SMS Pharmaceuticals Limited (SMSPHARMA)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when SMSPHARMA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SMSPHARMA — Free💡 Ask AI about this filing
📊 More SMSPHARMA filings
- 🔴 Corporate Action — 27 August 2026 SMS Pharmaceuticals Ltd revised its 38th AGM date to 29 September 2026 via video conference, moved t...
- 🟡 Board Meeting — 27 August 2026 SMS Pharmaceuticals announced a revised schedule for its 38th AGM, moving the meeting to September 2...
- 🟡 Board Meeting — 6 August 2026 SMS Pharmaceuticals announced a recommended final dividend of Rs.0.40 per share for FY2025-26, subje...
- Announcement — 1 August 2026 SMS Pharmaceuticals Limited presented its Q1FY27 investor deck highlighting 6% YoY revenue growth to...
- 🔴 Financial Results — 1 August 2026 SMS Pharmaceuticals reported Q1FY27 revenue of ₹207.0 crore, up 6% YoY, driven by broad-based growth...
🔥 Also filed on 22 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SMSPHARMA files new disclosures
Track SMSPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SMSPHARMA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd